Study Data from Emma Children's Hospital Update Knowledge of Cerebrotendinous Xanthomatosis (Newborn Screening for Cerebrotendinous Xanthomatosis: a Retrospective Biomarker Study Using Both Flow-injection and Uplc-ms/ms Analysis In Newborns).

Amsterdam, Netherlands, Europe, Biomarkers, Diagnostics and Screening, Health and Medicine, Lipid Metabolism Disorders, Metabolic Diseases and Conditions, Nutritional and Metabolic Diseases and Conditions, Xanthomatosis, Cerebrotendinous Xanthomatosis According to the news editors, the research concluded: "Newborn screening for CTX using only metabolite ratios following the measurement of three CTX biomarkers is possible using either FIA-MS/MS or UPLC-MS/MS, which paves the way for introduction of CTX NBS." Keywords: Amsterdam; Netherlands; Europe; Biomarkers; Cerebrotendinous Xanthomatosis; Diagnostics and Screening; Health and Medicine; Lipid Metabolism Disorders; Metabolic Diseases and Conditions; Nutritional and Metabolic Diseases and Conditions; Xanthomatosis EN Amsterdam Netherlands Europe Biomarkers Cerebrotendinous Xanthomatosis Diagnostics and Screening Health and Medicine Lipid Metabolism Disorders Metabolic Diseases and Conditions Nutritional and Metabolic Diseases and Conditions Xanthomatosis 2023 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Nutritional and Metabolic Diseases and Conditions - Cerebrotendinous Xanthomatosis are presented in a new report. [Extracted from the article]

Copyright of Health & Medicine Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)